Monoclonal antibody is produced by immunizing animals with a recombinant protein corresponding to the extracellular domain of human EGFR1 protein.
该单克隆抗体通过用重组蛋白免疫动物制备，该重组蛋白是人egfr1蛋白胞外结构域附近的残基。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the the human PINCH protein.
该单克隆抗体由人PINCH蛋白特异性的重组蛋白免疫动物产生。
Monoclonal antibody is produced by immunizing animals with a recombinant protein corresponding to residues near the carboxy terminal region of human FGF receptor 2 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白是人FGF受体2蛋白羧基末端区域的残基。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human GR protein.
该单克隆抗体是由对应人糖皮质激素受体蛋白靠近氨基末端残基的重组蛋白免疫动物而生产的。
The recombinant human protein kinase CK2 may be used as a molecular target for simpler screening and development of more effective inhibitors of CK2.
重组人蛋白激酶CK2可作为一种较为简便筛选和开发有效的CK 2抑制剂的分子靶点。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the carboxy terminus of human FGF receptor 1 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白是人FGF受体1蛋白的羧基末端。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the carboxy terminus of human FGF receptor 1 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白是针对人FGF受体1蛋白的羧基末端。
Monoclonal antibody is produced by immunizing animals with a recombinant protein containing the carboxy-terminal 150 amino acid residues of human VEGF receptor 2 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的，该重组蛋白包含人VEGF受体2蛋白羧基末端150氨基酸残基。
Objective To develop a method for the purification of recombinant human collagen-like protein.
目的建立重组类人胶原蛋白分离及纯化工艺。
Monoclonal antibody is produced by immunizing animals with a recombinant fusion protein surrounding amino acid 1475 of human ALK.
单克隆抗体由包含人ALK氨基酸1475的重组融合蛋白对动物进行免疫得到。
Monoclonal antibody is produced by immunizing animals with a recombinant protein corresponding to the amino terminus of human JNK1.
该单克隆抗体通过使用与人源JNK1蛋白胺端序列相一致的重组蛋白免疫动物而获得。
Monoclonal antibody is produced by immunizing animals with a recombinant human cdc2 fusion protein.
该单克隆抗体是由重组人cdc2融合蛋白免疫动物而生产的。
Objective To investigate the effect of the recombinant human bone morphogenetic protein-2 (BMP-2) on the healing pattern of a tendon in bone tunnel with the suspending fixation.
目的研究骨形态发生蛋白- 2 (BMP - 2)对悬吊固定后肌腱在骨隧道内愈合方式的影响。
Conclusion The recombinant human L-selectin protein can express with high efficiency in E. coli M15. The prepared polyclonal antibody has a high titer.
结论：人l -选择素蛋白可在M15大肠杆菌中高效表达，其多克隆抗体效价较高。
Human G-protein PAF receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed.
本发明公开了人G蛋白PAF受体多肽和编码这种多肽的DNA (RNA)以及通过重组技术产生这种多肽的方法。
Monoclonal antibody is produced by immunizing animals with a recombinant protein from the central region of human harmartin.
该单克隆抗体是由人源错构瘤蛋白（hamartin）中心区域的合成肽段免疫动物而生产的。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki- 67蛋白的氨基端邻近残基序列一致。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki-67蛋白的氨基端一致。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki-67蛋白的氨基端一致。
应用推荐